Squarepoint’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.5M | Buy |
452,564
+418,734
| +1,238% | +$32.3M | 0.04% | 482 |
|
|
2025
Q4 | $2.68M | Sell |
33,830
-1,782,409
| -98% | -$141M | ﹤0.01% | 1855 |
|
|
2025
Q3 | $137M | Buy |
1,816,239
+275,769
| +18% | +$18.9M | 0.14% | 145 |
|
|
2025
Q2 | $106M | Buy |
1,540,470
+1,401,359
| +1,007% | +$91.9M | 0.11% | 193 |
|
|
2025
Q1 | $9.42M | Sell |
139,111
-7,355
| -5% | -$440K | 0.01% | 1055 |
|
|
2024
Q4 | $6.57M | Sell |
146,466
-947,573
| -87% | -$53.2M | 0.01% | 1426 |
|
|
2024
Q3 | $68.8M | Buy |
1,094,039
+198,328
| +22% | +$11.6M | 0.11% | 168 |
|
|
2024
Q2 | $52.9M | Buy |
895,711
+675,136
| +306% | +$42.2M | 0.09% | 217 |
|
|
2024
Q1 | $17.6M | Sell |
220,575
-90,105
| -29% | -$6.88M | 0.03% | 673 |
|
|
2023
Q4 | $24.5M | Sell |
310,680
-434,659
| -58% | -$30.9M | 0.05% | 480 |
|
|
2023
Q3 | $52M | Sell |
745,339
-1,164,586
| -61% | -$82.5M | 0.13% | 159 |
|
|
2023
Q2 | $132M | Sell |
1,909,925
-187,479
| -9% | -$13.3M | 0.4% | 27 |
|
|
2023
Q1 | $156M | Buy |
2,097,404
+1,570,529
| +298% | +$132M | 0.64% | 9 |
|
|
2022
Q4 | $49.1M | Buy |
526,875
+246,630
| +88% | +$23.8M | 0.19% | 91 |
|
|
2022
Q3 | $26.7M | Sell |
280,245
-364,552
| -57% | -$36.1M | 0.13% | 154 |
|
|
2022
Q2 | $59.7M | Buy |
644,797
+616,068
| +2,144% | +$60.1M | 0.33% | 56 |
|
|
2022
Q1 | $2.91M | Sell |
28,729
-590,063
| -95% | -$62M | 0.01% | 933 |
|
|
2021
Q4 | $63.8M | Buy |
618,792
+39,352
| +7% | +$3.64M | 0.17% | 97 |
|
|
2021
Q3 | $49.2M | Buy |
579,440
+346,931
| +149% | +$29.1M | 0.14% | 140 |
|
|
2021
Q2 | $19.4M | Buy |
232,509
+143,026
| +160% | +$11.7M | 0.07% | 240 |
|
|
2021
Q1 | $6.73M | Buy |
89,483
+9,472
| +12% | +$690K | 0.04% | 508 |
|
|
2020
Q4 | $5.46M | Sell |
80,011
-574,005
| -88% | -$37.3M | 0.04% | 449 |
|
|
2020
Q3 | $38.2M | Buy |
654,016
+565,250
| +637% | +$35.2M | 0.51% | 21 |
|
|
2020
Q2 | $5.77M | Sell |
88,766
-214,255
| -71% | -$13.5M | 0.09% | 297 |
|
|
2020
Q1 | $18M | Buy |
+303,021
| New | +$20.2M | 0.46% | 29 |
|
|
2019
Q4 | – | Sell |
-279,608
| Closed | -$17.6M | – | 2527 |
|
|
2019
Q3 | $17.6M | Sell |
279,608
-1,073,800
| -79% | -$63.6M | 0.16% | 152 |
|
|
2019
Q2 | $73.7M | Sell |
1,353,408
-379,765
| -22% | -$20.5M | 0.72% | 11 |
|
|
2019
Q1 | $93.5M | Buy |
1,733,173
+820,341
| +90% | +$50.6M | 0.99% | 5 |
|
|
2018
Q4 | $59.8M | Buy |
912,832
+870,985
| +2,081% | +$65M | 0.7% | 12 |
|
|
2018
Q3 | $3.29M | Buy |
+41,847
| New | +$2.99M | 0.04% | 538 |
|
|
2018
Q2 | – | Sell |
-627,619
| Closed | -$39M | – | 1788 |
|
|
2018
Q1 | $39M | Buy |
627,619
+500,421
| +393% | +$35.9M | 0.62% | 15 |
|
|
2017
Q4 | $9.22M | Buy |
127,198
+22,578
| +22% | +$1.64M | 0.16% | 137 |
|
|
2017
Q3 | $8.51M | Buy |
+104,620
| New | +$8.28M | 0.16% | 155 |
|
|
2017
Q2 | – | Sell |
-314,461
| Closed | -$24.7M | – | 1573 |
|
|
2017
Q1 | $24.7M | Buy |
314,461
+170,755
| +119% | +$13.6M | 0.68% | 13 |
|
|
2016
Q4 | $11.3M | Buy |
143,706
+66,125
| +85% | +$5.35M | 0.46% | 37 |
|
|
2016
Q3 | $6.9M | Sell |
77,581
-116,556
| -60% | -$11M | 0.46% | 36 |
|
|
2016
Q2 | $18.6M | Buy |
194,137
+190,018
| +4,613% | +$18.9M | 1.16% | 3 |
|
|
2016
Q1 | $427K | Buy |
+4,119
| New | +$401K | 0.03% | 683 |
|
|
2015
Q4 | – | Sell |
-52,131
| Closed | -$5.03M | – | 1247 |
|
|
2015
Q3 | $5.03M | Buy |
+52,131
| New | +$5.48M | 1.26% | 11 |
|
|
2015
Q2 | – | Sell |
-19,886
| Closed | -$2.05M | – | 489 |
|
|
2015
Q1 | $2.05M | Buy |
19,886
+14,986
| +306% | +$1.52M | 0.72% | 21 |
|
|
2014
Q4 | $472K | Buy |
+4,900
| New | +$432K | 0.46% | 80 |
|
Other funds holding CVS
VCM
VPM
Squarepoint's CVS Position: Q1 2026 in Review
Squarepoint increased its CVS Health (CVS) stake by 1,238% in Q1 2026, buying an estimated $32.3M and bringing the position to 452,564 shares worth $32.5M. The position accounts for 0.04% of the portfolio, ranked #482.
Squarepoint first reported a position in CVS in Q4 2014 and has held it in 41 quarters since. The position peaked at $156M in Q1 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Squarepoint held 452,564 shares of CVS Health worth $32.5M as of Q1 2026.
- Squarepoint bought 418,734 CVS Health shares in Q1 2026, an estimated $32.3M.
- CVS Health made up 0.04% of Squarepoint's portfolio in Q1 2026, its #482 holding.
- Squarepoint first reported a position in CVS Health in Q4 2014 and has held it in 41 quarters since.
- Squarepoint's CVS Health position peaked at $156M in Q1 2023.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.